The unidimensional self-efficacy scale for MS (USE-MS): Developing a patient based and patient reported outcome

Multiple Sclerosis Journal

Volumn 18, Issue 9, 2012, Pages 1326-1333

  Young, C A ^a   Mills, R J ^b   Woolmore, J ^c   Hawkins, C P ^d   Tennant, A ^e  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^e UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

multiple sclerosis; patient outcome assessment; Psychometrics; quality of life; Rasch analysis; self efficacy

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; CONSTRUCT VALIDITY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PSYCHOMETRY; QUESTIONNAIRE; RASCH ANALYSIS; RATING SCALE; SELF CONCEPT; SELF REPORT; SEX; TREATMENT OUTCOME; UNIDIMENSIONAL SELF EFFICACY SCALE FOR MULTIPLE SCLEROSIS;

EID: 84866033777     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512436592     Document Type: Article

References (53)

1. Compston A, Confavreux C, Lassmann H 4 ed.Edinburgh: Churchill Livingstone, 2006. Edinburgh: Churchill Livingstone ; 2006:
2. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology. 2008 ; 71: 129-135
3. Wassem R. Self-efficacy as a predictor of adjustment to multiple sclerosis. Journal of Neuroscience Nursing. 1992 ; 25: 224-229
4. Mohr DC, Boudewyn AC, Likosky W, Levine E, Goodkin DE. Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and infection anxiety on adherence and ability to self-inject. Annals of Behavioral Medicine. 2001 ; 23: 125-132
5. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychological Review. 1977 ; 84: 191-215
6. Bandura A Social foundations of thought and action: A social cognitive theory. Englewood Cliffs, NJ: Prentice Hall ; 1986:
7. Fraser C, Hadjimichael O, Vollmer T. Predictors of adherence to Copaxone therapy in individuals with relapsing-remitting multiple sclerosis. The Journal of neuroscience nursing. 2001 ; 33: 231-239
8. Riazi A, Thompson AJ, Hobart JC. Self-efficacy predicts self-reported health status in multiple sclerosis. Multiple Sclerosis. 2004 ; 10: 61-66
9. Motl RW, Snook EM, McAuley E, Gliottoni RC. Symptoms, self-efficacy, and physical activity among individuals with multiple sclerosis. Research in Nursing & Health. 2006 ; 29: 597-606
10. Morris KS, McAuley E, Motl RW. Self-efficacy and environmental correlates of physical activity among older women and women with multiple sclerosis. Health Education Research. 2008 ; 23: 744-752
11. Stuifbergen AK, Seraphine A, Roberts G. An explanatory model of health promotion and quality of life in chronic disabling conditions. Nurs Res. 2000 ; 49: 122-129
12. Fraser C, Polito S. A comparative study of self-efficacy in men and women with multiple sclerosis. J Neurosci Nurs. 2007 ; 39: 102-106
13. Motl RW, Snook EM. Physical activity, self-efficacy, and quality of life in multiple sclerosis. Annals of Behavioral Medicine. 2008 ; 35: 111-115
14. Wollin JA, Fulcher G, McDonald E, et al. Psychosocial factors that influence quality of life and potential for self-management in multiple sclerosis. Int J MS Care. 2010 ; 12: 133-141
15. Sarkar U, Fisher L, Schillinger D. Is self-efficacy associated with diabetes self-management across race/ethnicity and health literacy?. Diabetes Care. 2006 ; 29: 823-829
16. Baldwin AS, Rothman AJ, Hertel AW, et al. Specifying the determinants of the initiation and maintenance of behavior change: An examination of self-efficacy, satisfaction, and smoking cessation. Health Psychology. 2006 ; 25: 626-634
17. Kavanagh DJ, Sitharthan T, Sayer GP. Prediction of results from correspondence treatment for controlled drinking. Addiction. 1996 ; 91: 1539-1545
18. Sitharthan T, Kavanagh DJ. Role of self-efficacy in predicting outcomes from a programme for controlled drinking. Drug Alcohol Depend. 1991 ; 27: 87-94
19. Greenfield SF, Hufford MR, Vagge LM, Muenz LR, Costello ME, Weiss RD. The relationship of self-efficacy expectancies to relapse among alcohol dependent men and women: a prospective study. Journal of Studies on Alcohol and Drugs. 2000 ; 61: 345-351
20. Yusaf S, Kavanagh DJ. The role of self-efficacy in the treatment of depression. Journal of Cognitive Psychotherapy. 1990 ; 4: 51-71
21. Sweet SN, Fortier MS, Guerin E, et al. Understanding physical activity in adults with type 2 diabetes after completing an exercise intervention trial: A mediation model of self-efficacy and autonomous motivation. Psychology, health & medicine. 2009 ; 14: 419-429
22. Sniehotta FF, Scholz U, Schwarzer R. Bridging the intention-behaviour gap: Planning, self-efficacy, and action control in the adoption and maintenance of physical exercise. Psychology & Health. 2005 ; 20: 143-160
23. Barnwell AM, Kavanagh DJ. Prediction of psychological adjustment to multiple sclerosis. Social Science and Medicine. 1997 ; 45: 411-418
24. Shnek ZM, Foley FW, LaRocca NG, et al. Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Annals of Behavioral Medicine. 1997 ; 19: 287-294
25. Shnek ZM, Foley FW, LaRocca NG, Smith CR, Halper J. Psychological predictors of depression in multiple sclerosis. J Neurol Rehabil. 1995 ; 9: 15-23
26. Tedman S, Thornton E, Baker G. Development of a scale to measure core beliefs and perceived self efficacy in adults with epilepsy. Seizure. 1995 ; 4: 221-231
27. Robinson-Smith G, Johnston MV, Allen J. Self-care self-efficacy, quality of life, and depression after stroke. Arch Phys Med Rehabil. 2000 ; 81: 460-464
28. Somers TJ, Shelby RA, Keefe FJ, et al. Disease severity and domain-specific arthritis self-efficacy: Relationships to pain and functioning in patients with rheumatoid arthritis. Arthritis Care & Research. 2010 ; 62: 848-856
29. Porter LS, Keefe FJ, Garst J, McBride CM, Baucom D. Self-efficacy for managing pain, symptoms, and function in patients with lung cancer and their informal caregivers: Associations with symptoms and distress. Pain. 2008 ; 137: 306-315
30. Mystakidou K, Parpa E, Tsilika E, et al. Self-efficacy, depression, and physical distress in males and females with cancer. Am J Hosp Palliat Care. 2010 ; 27: 518-525
31. Simmons RD, Ponsonby A-L, van der Mei IAF, Sheridan P. What affects your MS? Responses to an anonymous, Internet-based epidemiological survey. Multiple Sclerosis. 2004 ; 10: 202-211
32. Schwartz CE, Coulthard-Morris L, Zeng Q, Retzlaff P. Measuring self-efficacy in people with multiple sclerosis: A validation study. Archives of Physical Medicine and Rehabilitation. 1996 ;: 77
33. Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum. 1989 ; 32: 37-44
34. Pesudovs K, Burr JM, Harley C, Elliott DB. The Development, Assessment, and Selection of Questionnaires. Optometry and Vision Science. 2007 ; 84: 663-674
35. Airlie J, Baker GA, Smith SJ, Young CA. Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale. Clin Rehabil. 2001 ; 15: 259-265
36. Rigby SA, Domenech C, Thornton EW, Tedman S, Young CA. Development and validation of a self-efficacy measure for people with multiple sclerosis: the Multiple Sclerosis Self-efficacy Scale. Mult Scler. 2003 ; 9: 73-81
37. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Annals of Neurology. 1983 ; 13: 227-231
38. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology. 2001 ; 50: 121-127
39. Barlow JH, Williams B, Wright C. The Generalized Self-Efficacy Scale in people with arthritis. Arthritis Care Res. 1996 ; 9: 189-196
40. Bartone PT, Ursano RJ, Wright KM, Ingraham LH. The impact of a military air disaster on the health of assistance workers. A prospective study. Journal of Nervous and Mental Disease. 1989 ; 177: 317-328
41. Rasch G Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press ; 1960:
42. Tennant A, McKenna SP, Hagell P. Application of Rasch analysis in the development and application of quality of life instruments. Value Health. 2004 ; 7: S22 - S26
43. Guttman LA Studies in social psychology in World War II. Stouffer SA Guttman LA Suchman FA Lazarsfeld PF Star SA Clausen JA, ed. Princeton: Princeton University Press ; 1950: 60-90.
44. Smith RM. Fit analysis in latent trait measurement models. J Appl Meas. 2000 ; 1: 199-218
45. Tennant A, Conaghan PG. The Rasch measurement model in rheumatology: What is it and why use it? When should it be applied, and what should one look for in a Rasch paper?. Arthritis Rheum. 2007 ; 57: 1358-1362
46. Andrich D. Cronbach's alpha in the presence of subscales. International Conference on Outcomes Measurement ; 2010 ; 2010..
47. Holland P, Wainer H Differential Item Functioning. Hilldale NJ: Lawrence Erlbaum Associates ; 1993:
48. Linacre J. Sample size and item calibration stability. Rasch Measurement Transactions. 1994 ; 7: 328
49. Linacre J. Understanding Rasch measurement: Optimizing rating scale category effectiveness. Journal of Applied Measurement. 2002 ; 3: 85-106
50. Andrich D, Lyne A, Sheridon B, Luo G Perth: RUMM Laboratory ; 2009:
51. Masters G. Rasch model for partial credit scoring. Psychometrika. 1982 ; 47: 149-174
52. Fisher RA. Two new properties of mathematical likelihood. Proceedings of Royal Society. 1934 ; 144: 285-307
53. Bandura A Encyclopedia of human behavior. Ramachaudran VS, ed. New York: Academic Press ; 1994: 77-81.